Skip to content

The Lipid-Rich Plaque Study

The Lipid-Rich Plaque (LRP) Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02033694
Acronym
LRP
Enrollment
1563
Registered
2014-01-13
Start date
2014-02-28
Completion date
2018-09-30
Last updated
2020-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerosis, Coronary Artery Disease

Keywords

Lipid, Vulnerable Plaque, Plaque, Cholesterol, Near Infrared Spectroscopy, NIRS-IVUS, Intravascular Ultrasound, Angiography, Coronary Imaging

Brief summary

The purpose of this study is to enhance medical knowledge of the causes of future coronary problems. Many studies in patients who have already experienced a coronary problem point to the danger associated with plaques that are rich in cholesterol. This study determines if the near-infrared method of detection of these fatty plaques can predict future events. If dangerous plaques can be identified, there are many treatments already available that could be tested for their ability to prevent coronary events.

Interventions

DEVICENIRS-IVUS Imaging (TVC Imaging System)

Diagnostic Imaging Catheter

Sponsors

Medstar Health Research Institute
CollaboratorOTHER
Infraredx
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

General Inclusion Criteria: * Subjects presenting for coronary angiography in whom IVUS imaging is likely to be performed for clinical purposes. * Greater than 18 years of age. * Clinical presenting symptoms meeting one of the three criteria below: 1. Subjects presenting with an acute coronary syndrome (ACS) including at least one of the following: 1. Elevated cardiac biomarkers with CK-MB or troponin greater than upper limits of normal; 2. ST depression or ST elevation \>1mm in 2 or more contiguous leads in the absence of LVH, paced rhythm, BBB or early repolarization; 3. A stabilized patient 24 to 72 hours post STEMI; 2. Unstable angina pectoris; 3. Stable angina pectoris and/or a positive functional study with evidence of ischemia. Angiographic Inclusion Criteria * At least one Suspected Index Culprit Lesion requiring imaging with IVUS and/or NIRS for clinical indications. * At least two native epicardial coronary arteries (which may include the Suspected Index Culprit Artery) eligible for imaging with NIRS-IVUS. IVUS/NIRS Imaging Inclusion Criterion * A minimum of a total 50 mm of coronary artery not involved in a prior or Index Procedure PCI (including the 5mm borders on either edge of the site receiving PCI) must be scanned. This 50mm total length may include contributions from the Suspected Index Culprit Arteries and from Index Non-Culprit Arteries. This total length must include contributions from two or more native imaged arteries.

Exclusion criteria

* Unstable patients (STEMI within the prior 24 hours; cardiogenic shock, hypotension needing inotropes, hypoxia needing intubation, and IABP) and patients that had a procedural complication (coronary dissection, perforation or a complication that would necessitate immediate-unplanned revascularization) during index PCI procedure. * History of CABG or planned CABG within 6 months following NIRS-IVUS imaging. * Patient has additional lesion(s) that needs a staged PCI. * Subject life expectancy is less than 2 years at time of index catheterization. * Subject with ejection fraction (EF) \<30%. * Subject pacemaker dependent/paced rhythm. * Subject pregnant and lactating. * Any other factor that the investigator feels would put the patient at increased risk or otherwise make the patient unsuitable for participation in the protocol * Patients undergoing performance of PCI in all three major vessels during the index PCI.

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants Stratified as Non-Index Culprit Lesion Related Major Adverse Cardiac Events (NC-MACE) or No NC-MACE and Association With maxLCBI4mm as a Continuous Variable2 yearsAssociation of maximum 4 mm Lipid Core Burden Index (maxLCBI4mm) as a continuous value in 100 unit increments in all imaged arteries and NC-MACE at both (1) Patient Level and (2) Plaque Level Non-Index Culprit Lesion related Major Adverse Cardiac Events (NC-MACE) is defined as a composite of: * cardiac death * cardiac arrest * non-fatal myocardial infarction (MI) * acute coronary syndrome * revascularization by coronary artery bypass graft (CABG) or percutaneous intervention (PCI) * rehospitalization for progressive angina, related to a non-index culprit lesion

Secondary

MeasureTime frameDescription
Number of Participants Stratified as NC-MACE or No NC-MACE and Association With maxLCBI4mm More Than a Threshold of 4002 yearsAssociation of maxLCBI4mm more than and less than a threshold of 400 in all imaged arteries and NC-MACE at both (1) Patient Level and (2) Plaque Level Non-Index Culprit Lesion related Major Adverse Cardiac Events (NC-MACE) is defined as a composite of: * cardiac death * cardiac arrest * non-fatal myocardial infarction (MI) * acute coronary syndrome * revascularization by coronary artery bypass graft (CABG) or percutaneous intervention (PCI) * rehospitalization for progressive angina, related to a non-index culprit lesion

Countries

Italy, Latvia, Netherlands, Slovakia, United Kingdom, United States

Participant flow

Recruitment details

Enrolled patients with a large LRP (Maximum Lipid Core Burden Index\>250 in 4 mm or maxLCBI4mm\>=250) were assigned to 2 year follow up to determine if a new coronary event had occurred. A randomly selected half of the patients with a small or no LRP (MaxLCBI4mm\<250) had 2 year follow up.

Pre-assignment details

A randomly selected half of the patients with a small or no LRP (MaxLCBI4mm\<250) did not have 2 year follow up and were not included in the primary analyses. This reduced the total number of patients followed for two years to 1271 patients.

Participants by arm

ArmCount
Participants With 2 Year Follow up
Participants with NIRS-IVUS imaging at baseline and assigned to follow up for Non-Index Culprit Lesion related Major Adverse Cardiac Events (NC-MACE) for 2 years
1,271
Total1,271

Baseline characteristics

CharacteristicParticipants With 2 Year Follow up
Age, Continuous64 years
STANDARD_DEVIATION 10.3
Race/Ethnicity, Customized
African American
158 Participants
Race/Ethnicity, Customized
Asian Pacific
44 Participants
Race/Ethnicity, Customized
Caucasian
942 Participants
Race/Ethnicity, Customized
Hispanic
101 Participants
Race/Ethnicity, Customized
Native American
0 Participants
Race/Ethnicity, Customized
Other
128 Participants
Region of Enrollment
Italy
10 Participants
Region of Enrollment
Latvia
10 Participants
Region of Enrollment
Netherlands
187 Participants
Region of Enrollment
Slovakia
17 Participants
Region of Enrollment
United Kingdom
46 Participants
Region of Enrollment
United States
1001 Participants
Sex: Female, Male
Female
388 Participants
Sex: Female, Male
Male
883 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 1,563
other
Total, other adverse events
0 / 1,563
serious
Total, serious adverse events
6 / 1,563

Outcome results

Primary

Number of Participants Stratified as Non-Index Culprit Lesion Related Major Adverse Cardiac Events (NC-MACE) or No NC-MACE and Association With maxLCBI4mm as a Continuous Variable

Association of maximum 4 mm Lipid Core Burden Index (maxLCBI4mm) as a continuous value in 100 unit increments in all imaged arteries and NC-MACE at both (1) Patient Level and (2) Plaque Level Non-Index Culprit Lesion related Major Adverse Cardiac Events (NC-MACE) is defined as a composite of: * cardiac death * cardiac arrest * non-fatal myocardial infarction (MI) * acute coronary syndrome * revascularization by coronary artery bypass graft (CABG) or percutaneous intervention (PCI) * rehospitalization for progressive angina, related to a non-index culprit lesion

Time frame: 2 years

Population: Patients assigned to 2 year follow up were analyzed, at the patient and plaque level, to test the association between maximum 4 mm Lipid Core Burden Index (maxLCBI4mm) and Non-Index Culprit Lesion related Major Adverse Cardiac Events (NC-MACE).

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Participants With 2 Year Follow upNumber of Participants Stratified as Non-Index Culprit Lesion Related Major Adverse Cardiac Events (NC-MACE) or No NC-MACE and Association With maxLCBI4mm as a Continuous VariableParticipants with NC-MACE104 Participants
Participants With 2 Year Follow upNumber of Participants Stratified as Non-Index Culprit Lesion Related Major Adverse Cardiac Events (NC-MACE) or No NC-MACE and Association With maxLCBI4mm as a Continuous VariableParticipants with No NC-MACE1167 Participants
Comparison: Hypothesis 1 (Vulnerable Patient Hypothesis) first fit a univariate proportional hazards regression model in which maxLCBI4mm is the only independent variable and NC-MACE during 2 years is the outcome. The null hypothesis tested by the Wald test that the regression coefficient in a proportional hazards regression model is significantly different from 0. This analysis determined whether maxLCBI4mmI is a risk factor for NC-MACE.p-value: 0.000495% CI: [1.09, 1.35]Regression, Cox
Comparison: Hypothesis 2 (Vulnerable Plaque Hypothesis) first fit a univariate proportional hazards regression model in which maxLCBI4mm in the coronary artery segment is the measure of exposure and NC-MACE during 2 years caused by a new culprit lesion in that segment is the outcome. This analysis was performed with adjustment for the potential clustering effect within patient utilizing the Wei, Lin and Weissfeld (WLW) methodology. This analysis determined whether maxLCBI4mm is a risk factor NC-MACE.p-value: <0.000195% CI: [1.3, 1.6]Regression, Cox
Secondary

Number of Participants Stratified as NC-MACE or No NC-MACE and Association With maxLCBI4mm More Than a Threshold of 400

Association of maxLCBI4mm more than and less than a threshold of 400 in all imaged arteries and NC-MACE at both (1) Patient Level and (2) Plaque Level Non-Index Culprit Lesion related Major Adverse Cardiac Events (NC-MACE) is defined as a composite of: * cardiac death * cardiac arrest * non-fatal myocardial infarction (MI) * acute coronary syndrome * revascularization by coronary artery bypass graft (CABG) or percutaneous intervention (PCI) * rehospitalization for progressive angina, related to a non-index culprit lesion

Time frame: 2 years

Population: Patients assigned to 2 year follow up were analyzed, at the patient and plaque level to test the association between maximum 4mm Lipid Core Burden index (maxLCBI4mm) \>400 and Non-Index Culprit Lesion related Major Cardiac Events (NC-MACE)

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Participants With 2 Year Follow upNumber of Participants Stratified as NC-MACE or No NC-MACE and Association With maxLCBI4mm More Than a Threshold of 400Participants with NC-MACE104 Participants
Participants With 2 Year Follow upNumber of Participants Stratified as NC-MACE or No NC-MACE and Association With maxLCBI4mm More Than a Threshold of 400Participants with No NC-MACE1167 Participants
Comparison: Secondary Hypothesis 1 (Vulnerable Patient)- Cox proportional hazards regression model to assess a threshold of maxLCBI4mm \> 400 as the independent variable and NC-MACE during 2 years as the outcome.p-value: <0.000195% CI: [1.48, 3.22]Regression, Cox
Comparison: Secondary Hypothesis 2 (Vulnerable Plaque)- Cox proportional hazards regression model to assess a threshold of maxLCBI4mm \> 400 in the coronary artery segment as the independent variable and NC-MACE during 2 years caused by a new culprit lesion in that segment is the outcome.p-value: <0.000195% CI: [2.39, 7.45]Regression, Cox

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026